Toggle navigation
Home
Search
Services
Blog
Contact
About
Identifying Ligands for A Novel Gabaa Receptor Subtype
Gee, Kelvin W.
Kadmus Pharmaceuticals, Inc., Irvine, CA, United States
Search 32 grants from Kelvin Gee
Search grants from Kadmus Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Endothelial targeting of antioxidants
Mechanisms of naturally-acquired immunity to malaria
Interstrand Crosslinking Repair and DNA Recombination
Linguistic Analyses of Tobacco Industry Documents
Indigenous Outreach Among Idus to Treat and Control Tb
Recently added grants:
Induction of Senescence using Dexamethasone to re-sensitize NSCLC to anti-PD1 therapy
Context-Dependent Effects of PARP Inhibitors on Breast Cancer Bone Metastasis
SAMHD1-mediated regulation of HIV-1 innate immunity and viral gene expression
HIV Vaccine Trials Network Laboratory Center
IMPAACT Leadership Group
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Small Business Technology Transfer (STTR) Grants - Phase I (R41)
Project #
1R41MH060527-01A1
Application #
6134497
Study Section
Special Emphasis Panel (ZRG1-MDCN-3 (02))
Program Officer
Murphy, Diane
Project Start
2000-06-01
Project End
2002-05-31
Budget Start
2000-06-01
Budget End
2002-05-31
Support Year
1
Fiscal Year
2000
Total Cost
$120,208
Indirect Cost
Institution
Name
Kadmus Pharmaceuticals, Inc.
Department
Type
DUNS #
City
Irvine
State
CA
Country
United States
Zip Code
92612
Related projects
NIH 2001
R41 MH
Identifying Ligands for A Novel Gabaa Receptor Subtype
Gee, Kelvin W. / Kadmus Pharmaceuticals, Inc.
$7,023
NIH 2000
R41 MH
Identifying Ligands for A Novel Gabaa Receptor Subtype
Gee, Kelvin W. / Kadmus Pharmaceuticals, Inc.
$120,208
Comments
Be the first to comment on this grant